Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial

Abstract Background Preoperative neoadjuvant chemotherapy (NACT) has been widely used in developing countries for the treatment of patients with International Federation of Gynecology and Obstetrics (FIGO) stages IB3 and IIA2 cervical cancer. However, the effectiveness of NACT and treatment options...

Full description

Bibliographic Details
Main Authors: Yingjie Hu, Yingyan Han, Yuanming Shen, Jing Chen, Yaheng Chen, Yile Chen, Junying Tang, Min Xue, Li Hong, Wenjun Cheng, Danbo Wang, Zhiqing Liang, Yifeng Wang, Qinghua Zhang, Hui Xing, Yu Zhang, Cunjian Yi, Zhiying Yu, Youguo Chen, Manhua Cui, Cailing Ma, Hongying Yang, Ruizhen Li, Ping Long, Yu Zhao, Pengpeng Qu, Guangshi Tao, Lihua Yang, Sufang Wu, Zhihua Liu, Ping Yang, Weiguo Lv, Xing Xie, Ding Ma, Hui Wang, Kezhen Li
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Cancer
Subjects:
Cervical cancer
Neoadjuvant chemotherapy
Radical surgery
Prognosis
Non-responders
Online Access:https://doi.org/10.1186/s12885-022-10355-3

Internet

https://doi.org/10.1186/s12885-022-10355-3

Similar Items